vs

Side-by-side financial comparison of Bowman Consulting Group Ltd. (BWMN) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Bowman Consulting Group Ltd. is the larger business by last-quarter revenue ($129.0M vs $127.1M, roughly 1.0× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 13.9%). Bowman Consulting Group Ltd. produced more free cash flow last quarter ($8.1M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 16.6%).

SLR Consulting is a privately owned international sustainability consultancy with offices in Europe, North America, South America, Australasia, and Africa. In 2019, it reported revenues of £150.8 million. Its purpose is ‘Making Sustainability Happen’, which it achieves through its global team of expert advisors and technicians, who partner with clients to tackle some of the world’s most complex sustainability challenges. Its ultimate owner is Solar Holdings Topco Limited.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

BWMN vs ZLAB — Head-to-Head

Bigger by revenue
BWMN
BWMN
1.0× larger
BWMN
$129.0M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+3.2% gap
ZLAB
17.1%
13.9%
BWMN
More free cash flow
BWMN
BWMN
$34.8M more FCF
BWMN
$8.1M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
16.6%
BWMN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BWMN
BWMN
ZLAB
ZLAB
Revenue
$129.0M
$127.1M
Net Profit
$2.0M
Gross Margin
55.0%
51.0%
Operating Margin
3.2%
-54.6%
Net Margin
1.5%
Revenue YoY
13.9%
17.1%
Net Profit YoY
-66.7%
EPS (diluted)
$0.13
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BWMN
BWMN
ZLAB
ZLAB
Q4 25
$129.0M
$127.1M
Q3 25
$126.0M
$115.4M
Q2 25
$122.1M
$109.1M
Q1 25
$112.9M
$105.7M
Q4 24
$113.2M
$108.5M
Q3 24
$113.9M
$101.8M
Q2 24
$104.5M
$100.1M
Q1 24
$94.9M
$87.1M
Net Profit
BWMN
BWMN
ZLAB
ZLAB
Q4 25
$2.0M
Q3 25
$6.6M
$-36.0M
Q2 25
$6.0M
$-40.7M
Q1 25
$-1.7M
$-48.4M
Q4 24
$5.9M
Q3 24
$771.0K
$-41.7M
Q2 24
$-2.1M
$-80.3M
Q1 24
$-1.6M
$-53.5M
Gross Margin
BWMN
BWMN
ZLAB
ZLAB
Q4 25
55.0%
51.0%
Q3 25
53.1%
59.5%
Q2 25
53.7%
60.6%
Q1 25
51.4%
63.6%
Q4 24
53.2%
61.5%
Q3 24
52.4%
64.1%
Q2 24
52.5%
64.9%
Q1 24
50.6%
61.4%
Operating Margin
BWMN
BWMN
ZLAB
ZLAB
Q4 25
3.2%
-54.6%
Q3 25
4.2%
-42.3%
Q2 25
7.4%
-50.3%
Q1 25
1.0%
-53.3%
Q4 24
1.2%
-62.6%
Q3 24
0.4%
-66.6%
Q2 24
-1.2%
-76.0%
Q1 24
-2.8%
-80.7%
Net Margin
BWMN
BWMN
ZLAB
ZLAB
Q4 25
1.5%
Q3 25
5.3%
-31.2%
Q2 25
4.9%
-37.3%
Q1 25
-1.5%
-45.8%
Q4 24
5.2%
Q3 24
0.7%
-40.9%
Q2 24
-2.0%
-80.2%
Q1 24
-1.6%
-61.4%
EPS (diluted)
BWMN
BWMN
ZLAB
ZLAB
Q4 25
$0.13
$-0.05
Q3 25
$0.37
$-0.03
Q2 25
$0.34
$-0.04
Q1 25
$-0.11
$-0.04
Q4 24
$0.37
$-0.09
Q3 24
$0.04
$-0.04
Q2 24
$-0.13
$-0.08
Q1 24
$-0.11
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BWMN
BWMN
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$11.1M
$689.6M
Total DebtLower is stronger
$57.6M
Stockholders' EquityBook value
$261.1M
$715.5M
Total Assets
$579.7M
$1.2B
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BWMN
BWMN
ZLAB
ZLAB
Q4 25
$11.1M
$689.6M
Q3 25
$16.2M
$717.2M
Q2 25
$15.5M
$732.2M
Q1 25
$10.7M
$757.3M
Q4 24
$6.7M
$779.7M
Q3 24
$11.7M
$616.1M
Q2 24
$23.1M
$630.0M
Q1 24
$11.7M
$650.8M
Total Debt
BWMN
BWMN
ZLAB
ZLAB
Q4 25
$57.6M
Q3 25
$29.8M
Q2 25
$32.0M
Q1 25
$36.4M
Q4 24
$38.1M
Q3 24
$36.4M
Q2 24
$38.8M
Q1 24
$26.8M
Stockholders' Equity
BWMN
BWMN
ZLAB
ZLAB
Q4 25
$261.1M
$715.5M
Q3 25
$261.8M
$759.9M
Q2 25
$249.6M
$791.7M
Q1 25
$244.1M
$810.8M
Q4 24
$246.1M
$840.9M
Q3 24
$243.2M
$667.7M
Q2 24
$235.6M
$704.2M
Q1 24
$167.3M
$762.2M
Total Assets
BWMN
BWMN
ZLAB
ZLAB
Q4 25
$579.7M
$1.2B
Q3 25
$510.2M
$1.2B
Q2 25
$538.2M
$1.2B
Q1 25
$528.7M
$1.2B
Q4 24
$505.9M
$1.2B
Q3 24
$497.0M
$985.3M
Q2 24
$463.4M
$987.4M
Q1 24
$420.5M
$988.4M
Debt / Equity
BWMN
BWMN
ZLAB
ZLAB
Q4 25
0.22×
Q3 25
0.11×
Q2 25
0.13×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.15×
Q2 24
0.16×
Q1 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BWMN
BWMN
ZLAB
ZLAB
Operating Cash FlowLast quarter
$9.4M
$-26.0M
Free Cash FlowOCF − Capex
$8.1M
$-26.7M
FCF MarginFCF / Revenue
6.3%
-21.0%
Capex IntensityCapex / Revenue
0.9%
0.5%
Cash ConversionOCF / Net Profit
4.76×
TTM Free Cash FlowTrailing 4 quarters
$33.4M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BWMN
BWMN
ZLAB
ZLAB
Q4 25
$9.4M
$-26.0M
Q3 25
$10.2M
$-32.0M
Q2 25
$4.3M
$-31.0M
Q1 25
$12.0M
$-61.7M
Q4 24
$11.9M
$-55.8M
Q3 24
$6.8M
$-26.8M
Q2 24
$3.1M
$-42.2M
Q1 24
$2.5M
$-90.1M
Free Cash Flow
BWMN
BWMN
ZLAB
ZLAB
Q4 25
$8.1M
$-26.7M
Q3 25
$10.1M
$-35.0M
Q2 25
$4.2M
$-33.9M
Q1 25
$11.0M
$-63.2M
Q4 24
$11.7M
$-58.4M
Q3 24
$6.6M
$-28.2M
Q2 24
$2.7M
$-42.9M
Q1 24
$2.3M
$-91.1M
FCF Margin
BWMN
BWMN
ZLAB
ZLAB
Q4 25
6.3%
-21.0%
Q3 25
8.0%
-30.4%
Q2 25
3.4%
-31.1%
Q1 25
9.7%
-59.9%
Q4 24
10.4%
-53.8%
Q3 24
5.8%
-27.7%
Q2 24
2.6%
-42.9%
Q1 24
2.4%
-104.5%
Capex Intensity
BWMN
BWMN
ZLAB
ZLAB
Q4 25
0.9%
0.5%
Q3 25
0.0%
2.6%
Q2 25
0.1%
2.6%
Q1 25
0.9%
1.5%
Q4 24
0.2%
2.4%
Q3 24
0.2%
1.3%
Q2 24
0.3%
0.7%
Q1 24
0.3%
1.1%
Cash Conversion
BWMN
BWMN
ZLAB
ZLAB
Q4 25
4.76×
Q3 25
1.54×
Q2 25
0.71×
Q1 25
Q4 24
2.02×
Q3 24
8.81×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BWMN
BWMN

Segment breakdown not available.

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons